{"version":"1.0","provider_name":"IRB USI","provider_url":"https:\/\/irb.usi.ch\/it\/","author_name":"Maryse","author_url":"https:\/\/irb.usi.ch\/it\/author\/maryse\/","title":"Engineered bacteria for cancer immunotherapy - IRB USI","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Oq544LPye6\"><a href=\"https:\/\/irb.usi.ch\/it\/news\/engineered-bacteria-for-cancer-immunotherapy\/\">Engineered bacteria for cancer immunotherapy<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/irb.usi.ch\/it\/news\/engineered-bacteria-for-cancer-immunotherapy\/embed\/#?secret=Oq544LPye6\" width=\"600\" height=\"338\" title=\"&#8220;Engineered bacteria for cancer immunotherapy&#8221; &#8212; IRB USI\" data-secret=\"Oq544LPye6\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/irb.usi.ch\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/irb.usi.ch\/images\/Nature_fig_Geiger_Sept2021_slider.jpg","thumbnail_width":1024,"thumbnail_height":480,"description":"Bellinzona, October 6th, 2021 \u2013 A Nature paper by the Systems Immunology group, headed by Roger Geiger, at the Institute for Research in Biomedicine (IRB, affiliated to USI). This study describes an innovative strategy to improve the anti-tumor activity of T cells, key players of the immune system with the ability to detect and kill [&hellip;]"}